ThermoGenesis Holdings is engaged in the development and commercialization of automated cell processing technologies for the cell and gene therapy field. Co. markets a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally closed CAR-TXpress™ platform. Co. provides the AutoXpress® and BioArchive platforms for automated clinical bio-banking, PXP platform for point-of-care cell-based therapies and CAR-TXpress™ platform under development for bio-manufacturing for immuno-oncology applications. Co. has two business segments: Device Segment and Clinical Development Segment. We show 19 historical shares outstanding datapoints in our THMO shares outstanding history coverage, used to compute THMO market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing THMO market cap history over the course of time is important for investors
interested in comparing THMO's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of THMO versus a peer is one thing; comparing
THMO market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like THMO can fluctuate over the course of history.
With this page we aim to empower investors researching THMO by allowing them to research the THMO market cap history. |
Free THMO Email Alerts:
Video: The Importance of Market Cap
